Professional
Added to YB: 2024-02-28
Pitch date: 2024-02-22
TECH [bullish]
Bio-Techne Corporation
-18.37%
current return
Author Info
No bio for this author
Company Info
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
Market Cap
$9.4B
Pitch Price
$71.34
Price Target
N/A
Dividend
0.53%
EV/EBITDA
26.95
P/E
115.41
EV/Sales
7.85
Sector
Life Sciences Tools and Services
Category
growth
Polen U.S. SMID Company Growth New Position - Bio-Techne Corporation
TECH: Leading protein sciences co. serving biopharma, academia & clinical markets. 10yr track record of differentiation, accelerating organic growth & 20%+ CFROIC. Near-term life sci headwinds create opportunity in high-quality flywheel biz w/ mid-to-high teens LT EPS growth potential & exposure to emerging biopharma minus binary risk.
Read full article (1 min)